Pricing Log in Create free account
Saturday 17 October 2026 Export BAX’s income statement to Excel — free account

Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Baxter International Inc. (BAX) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Baxter International Inc. (BAX) trades at a price to free cash flow of 16.1×. Over the past ten years it has ranged from 7.6× (September 2015) to 85.5× (March 2025); the current reading is higher than 14% of that period. That is below the Medical Instruments & Supplies industry median of 25.2× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 29.5× 13.77%
FY2024 26.0× 70.84%
FY2023 15.2× (50.75%)
FY2022 30.8× 9.59%
FY2021 28.1× (20.13%)
FY2020 35.2× 16.57%
FY2019 30.2× 16.80%
FY2018 25.9× (22.08%)
FY2017 33.2× 28.00%
FY2016 26.0× 6.95%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 13.5× 13.02%
Mar 2026 12.0× (59.47%)
Dec 2025 29.5× (38.44%)
Sep 2025 48.0× (26.82%)
42 more quarters

Against its own ten years

Low 7.6× High 85.5×
Ten-year median 27.9×
Current reading's percentile 14

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
ALGN Align Technology, Inc. compare 15.6×
BAX Baxter International Inc. 16.1×
COO The Cooper Companies, Inc. compare 16.5×
AVTR Avantor, Inc. compare 24.4×
ATR AptarGroup, Inc. compare 25.2×
BLCO Bausch + Lomb Corporation compare 52.3×
WST West Pharmaceutical Services, Inc. compare 62.6×
RGEN Repligen Corporation compare 162×
Medical Instruments & Supplies industry median 25.2×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on BAX